rizatriptan has been researched along with Coronary Artery Disease in 1 studies
rizatriptan: structure given in first source; RN given refers to benzoate
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edvinsson, L | 1 |
| Uddman, E | 1 |
| Wackenfors, A | 1 |
| Davenport, A | 1 |
| Longmore, J | 1 |
| Malmsjö, M | 1 |
1 other study available for rizatriptan and Coronary Artery Disease
| Article | Year |
|---|---|
Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect.
Topics: Adult; Cerebral Arteries; Coronary Artery Disease; Coronary Vessels; Dose-Response Relationship, Dru | 2005 |